1-4 of 4
Katrin Salva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides or Sezary Syndrome: Final Results Show Significant Clinical Activity and Suggest Correlation with CD30 Expression

Youn H. Kim, MD, Mahkam Tavallaee, MD MPH, Sima Rozati, MD, Uma Sundram, MD PhD, Katrin Salva, MD, Gary S. Wood, MD, Shufeng Li, MS, Michael Krathen, MD, Seema Nagpal, MD, Sunil Reddy, MD, Randall Armstrong, Richard T. Hoppe, MD, Melissa Pulitzer, MD, Ranjana H Advani, MD, Steven M. Horwitz, MD
Journal: Blood
Blood (2014) 124 (21): 804.
https://doi.org/10.1182/blood.V124.21.804.804
Published: 2014
Journal Articles

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event

Clinical Trials & Observations
Mitul D. Gandhi, Andrew M. Evens, Timothy S. Fenske, Paul Hamlin, Bertrand Coiffier, Andreas Engert, Alison J. Moskowitz, Nilanjan Ghosh, Adam M. Petrich, Jon Lomasney, Amy Chadburn, Gary S. Wood, Katrin Salva, Beatrice Nardone, Steven M. Trifilio, Dennis W. Raisch, Dennis P. West, Leo I. Gordon, Jane N. Winter
Journal: Blood
Blood (2014) 123 (18): 2895–2897.
https://doi.org/10.1182/blood-2014-03-561878
Published: 2014
Journal Articles

Pancreatitis In Patients Treated With Brentuximab Vedotin: A Previously Unrecognized Serious Adverse Event

Mitul Gandhi, MD, Andrew M Evens, DO, MSc, Timothy S. Fenske, MD, Paul Hamlin, MD, Bertrand Coiffier, MD, PhD, Andreas Engert, MD, Alison J. Moskowitz, MD, Nilanjan Ghosh, MD, PhD, Adam M. Petrich, MD, Jon Lomasney, M.D., Amy Chadburn, M.D., Gary S. Wood, MD, Katrin Salva, M.D., Steven M Trifilio, BS Pharm, Dennis W. Raisch, PhD, MS, RPh, Dennis West, PhD, Leo I. Gordon, MD, Jane N. Winter, MD
Journal: Blood
Blood (2013) 122 (21): 4380.
https://doi.org/10.1182/blood.V122.21.4380.4380
Published: 2013
Journal Articles

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression

Michael Krathen, MD, Uma Sundram, MD, PhD, Sameer Bashey, MD, Katherine Sutherland, C-PA, Katrin Salva, MD, Gary S Wood, MD, Ranjana H. Advani, MD, Richard T. Hoppe, MD, Sunil Reddy, MD, Randall Armstrong, Seema Nagpal, MD, Melissa Pulitzer, MD, Steven M. Horwitz, MD, Youn H. Kim, MD
Journal: Blood
Blood (2012) 120 (21): 797.
https://doi.org/10.1182/blood.V120.21.797.797
Published: 2012